Physician profile
Cherison A Cuffy
NPI 1407081813
$15,811.38
in general payments reported to CMS, 2019-2025
37 companies · $4,149 in 2025
The $4,149 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,177 · 2020: $982 · 2021: $1,209 · 2022: $1,596 · 2023: $1,596 · 2024: $2,102 · 2025: $4,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,636 · Consulting Fee: $1,500 · Travel and Lodging: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,636.34 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $711.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,924.07 | 2019-2025 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Southern Edge Orthopaedics, INC. | $2,058.26 | 2019-2025 | |
| Organogenesis INC. | $1,512.71 | 2019-2025 | Apligraf, Puraply |
| Stryker Corporation | $1,155.16 | 2020-2025 | Infinity Adaptis, Salvation, Prophecy |
| Integra Lifesciences Corporation | $985.90 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $914.07 | 2025 | Truelok |
| Kerecis Limited | $706.20 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Kci USA, INC. | $367.72 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Wright Medical Technology, INC. | $354.32 | 2019 | |
| Horizon Therapeutics Plc | $339.68 | 2019-2023 | Krystexxa |
| Biotissue Holdings INC. | $330.06 | 2022-2023 | |
| Solventum Corporation | $298.61 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo, V.A.C.Ulta |
| Depuy Synthes Sales INC. | $248.39 | 2021-2024 | Healix Knotless Peek, Motoband |
| Nevro Corp. | $233.52 | 2022 | |
| Polynovo North America LLC | $216.18 | 2022-2024 | Novosorb Btm |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $208.40 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $184.54 | 2021-2025 | Nuzyra |
| Mimedx Group, INC. | $176.32 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $164.89 | 2020 | |
| Aroa Biosurgery Incorporated | $155.65 | 2023 | |
| Urgo Medical North America, LLC | $139.02 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Osiris Therapeutics INC. | $128.46 | 2019 | |
| Amgen INC. | $116.84 | 2024 | Krystexxa |
| Lifenet Health | $105.75 | 2024 | Theragenesis Wound Matrix |
| Cook Medical LLC | $104.49 | 2019 | |
| Paragon 28, INC. | $93.27 | 2019 | |
| Globus Medical, INC. | $80.00 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $78.89 | 2023 | Seglentis |
| Melinta Therapeutics, LLC | $77.41 | 2021 | |
| Medtronic, INC. | $77.22 | 2023-2024 | Intellis Adaptivestim |
| Treace Medical Concepts, INC. | $72.81 | 2023-2025 | |
| Ets Wound Care LLC | $63.58 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Innovation Technologies INC | $62.42 | 2022-2023 | Irrisept |
| Trilliant Surgical LLC. | $22.93 | 2022 | |
| Acell, INC. | $19.93 | 2020 | |
| Acera Surgical, INC. | $18.22 | 2022 | |
| Bioventus LLC | $15.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherison Cuffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.